Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Applied Dna Scns (APDN)

Applied Dna Scns (APDN)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 44,241
  • Shares Outstanding, K 7,473
  • Annual Sales, $ 1,930 K
  • Annual Income, $ -13,030 K
  • 60-Month Beta 1.03
  • Price/Sales 24.37
  • Price/Cash Flow N/A
  • Price/Book 8.51
Trade APDN with:

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 3 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/21
See More
  • Average Estimate -0.17
  • Number of Estimates 2
  • High Estimate -0.11
  • Low Estimate -0.24
  • Prior Year -0.79
  • Growth Rate Est. (year over year) +78.48%

Price Performance

See More
Period Period Low Period High Performance
1-Month
5.85 +1.85%
on 04/20/21
9.96 -40.18%
on 04/07/21
-2.81 (-32.06%)
since 03/19/21
3-Month
5.85 +1.85%
on 04/20/21
13.64 -56.32%
on 02/11/21
-5.05 (-45.88%)
since 01/20/21
52-Week
4.95 +20.37%
on 12/21/20
16.39 -63.65%
on 05/14/20
+0.53 (+9.73%)
since 04/20/20

Most Recent Stories

More News
Applied DNA and Evvivax Announce Positive Preliminary Results of Phase I Clinical Trial for LinearDNA(TM) COVID-19 Vaccine Candidate in Felines

--- Strong Neutralizing Antibody Titer Elicited Across Cohort -

APDN : 5.96 (+0.68%)
Applied DNA CEO Discusses Relevance of DNA-based Cotton Traceability as Enabler of Ethical and Responsible Textile Manufacturing on BBC Business Daily

Applied DNA Sciences, Inc. (NASDAQ: APDN) (Applied DNA or the "Company"), a leader in Polymerase Chain Reaction (PCR)-based DNA manufacturing, announced an interview with President and CEO Dr. James A....

APDN : 5.96 (+0.68%)
Applied DNA Sciences (APDN) Moves 13.2% Higher: Will This Strength Last?

Applied DNA Sciences (APDN) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength...

APDN : 5.96 (+0.68%)
Applied DNA Sciences (APDN) Upgraded to Buy: Here's What You Should Know

Applied DNA Sciences (APDN) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

APDN : 5.96 (+0.68%)
Applied DNA and Northwell Health Establish SARS-CoV-2 Mutation and Variant Tracking Program

-- - Program Powered by Applied DNA's Mutation-targeted qPCR Assays and NGS Platform -

APDN : 5.96 (+0.68%)
Applied DNA Appoints Clay Shorrock as Chief Legal Officer and Executive Director of Business Development

Applied DNA Sciences, Inc. (NASDAQ: APDN) (the "Company"), a leader in Polymerase Chain Reaction (PCR)-based DNA manufacturing, today announced that Clay Shorrock, J.D., has rejoined the Company effective...

APDN : 5.96 (+0.68%)
Applied DNA Receives Blanket Purchase Order for Linea(TM) COVID-19 Assay Kits for 10,000 Tests

Applied DNA Sciences, Inc. (NASDAQ: APDN) (the "Company"), a leader in Polymerase Chain Reaction (PCR)-based DNA manufacturing, today announced the receipt of a purchase order for its Linea(TM) COVID-19...

APDN : 5.96 (+0.68%)
Applied DNA Launches Linea(TM) COVID-19 Selective Genomic Surveillance(TM) Mutation Panel to Boost SARS-CoV-2 Variant Detection and Tracking Nationally

--Newly Developed PCR Panel Detects Specific Mutations to Focus Limited NGS Capacity on Most Impactful Variants of SARS-CoV-2

APDN : 5.96 (+0.68%)
Applied DNA to Participate in Upcoming Conferences

Applied DNA Sciences, Inc. (NASDAQ: APDN) ("Applied DNA" or the "Company"), a leader in Polymerase Chain Reaction (PCR)-based DNA manufacturing, will be participating in the following virtual investor...

APDN : 5.96 (+0.68%)
Thinking about buying stock in Greenlane Holdings, vTv Therapeutics, Evolus Inc, Applied DNA Sciences, or Mogo Inc?

, /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for GNLN, VTVT, EOLS, APDN, and MOGO.

EOLS : 10.70 (+0.75%)
GNLN : 4.60 (-6.50%)
VTVT : 2.34 (-3.70%)
APDN : 5.96 (+0.68%)
MOGO : 6.60 (-5.04%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 48% Sell with a Strengthening short term outlook on maintaining the current direction.

The market is in highly oversold territory. Beware of a trend reversal.

See More Share

Business Summary

Applied DNA Sciences, Inc. provides proprietary DNA-embedded biotechnology security solutions, using non-human DNA, that verify authenticity and protect corporate and government agencies from counterfeiting, fraud, piracy, product diversion, identity theft and unauthorized intrusion. They develop, market,...

See More

Key Turning Points

3rd Resistance Point 6.75
2nd Resistance Point 6.57
1st Resistance Point 6.25
Last Price 5.96
1st Support Level 5.75
2nd Support Level 5.57
3rd Support Level 5.24

See More

52-Week High 16.39
Fibonacci 61.8% 12.02
Fibonacci 50% 10.67
Fibonacci 38.2% 9.32
Last Price 5.96
52-Week Low 4.95

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar